These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15317288)

  • 1. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).
    Maryanoff BE; Zhang HC; Andrade-Gordon P; Derian CK
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):13-36. PubMed ID: 15317288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.
    Andrade-Gordon P; Maryanoff BE; Derian CK; Zhang HC; Addo MF; Darrow AL; Eckardt AJ; Hoekstra WJ; McComsey DF; Oksenberg D; Reynolds EE; Santulli RJ; Scarborough RM; Smith CE; White KB
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12257-62. PubMed ID: 10535908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-derived protease-activated receptor-1 (PAR-1) antagonists.
    Seiler SM; Bernatowicz MS
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):1-11. PubMed ID: 15317287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1.
    Selnick HG; Barrow JC; Nantermet PG; Connolly TM
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):47-59. PubMed ID: 15317290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent non-peptide thrombin receptor antagonists.
    Chackalamannil S; Ahn HS; Xia Y; Doller D; Foster C
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):37-45. PubMed ID: 15317289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RWJ-58259: a selective antagonist of protease activated receptor-1.
    Damiano BP; Derian CK; Maryanoff BE; Zhang HC; Gordon PA
    Cardiovasc Drug Rev; 2003; 21(4):313-26. PubMed ID: 14647534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.
    Andrade-Gordon P; Derian CK; Maryanoff BE; Zhang HC; Addo MF; Cheung Wm ; Damiano BP; D'Andrea MR; Darrow AL; de Garavilla L; Eckardt AJ; Giardino EC; Haertlein BJ; McComsey DF
    J Pharmacol Exp Ther; 2001 Jul; 298(1):34-42. PubMed ID: 11408522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif.
    Hoekstra WJ; Hulshizer BL; McComsey DF; Andrade-Gordon P; Kauffman JA; Addo MF; Oksenberg D; Scarborough RM; Maryanoff BE
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1649-54. PubMed ID: 9873407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.
    Anderluh M; Dolenc MS
    Curr Med Chem; 2002 Jul; 9(13):1229-50. PubMed ID: 12052165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
    Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
    J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds.
    Severino B; Fiorino F; Perissutti E; Frecentese F; Cirino G; Roviezzo F; Santagada V; Caliendo G
    Bioorg Med Chem; 2008 Jun; 16(11):6009-20. PubMed ID: 18477511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases.
    Ahn HS; Chackalamannil S; Boykow G; Graziano MP; Foster C
    Curr Pharm Des; 2003; 9(28):2349-65. PubMed ID: 14529396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for the presence of an atypical protease-activated receptor on rat platelets.
    Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
    Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
    Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
    Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.
    Ahn HS; Foster C; Boykow G; Stamford A; Manna M; Graziano M
    Biochem Pharmacol; 2000 Nov; 60(10):1425-34. PubMed ID: 11020444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
    Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
    Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1).
    McComsey DF; Hawkins MJ; Andrade-Gordon P; Addo MF; Oksenberg D; Maryanoff BE
    Bioorg Med Chem Lett; 1999 May; 9(10):1423-8. PubMed ID: 10360749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein coupled receptor antagonists-1: protease activated receptor-1 (PAR-1) antagonists as novel cardiovascular therapeutic agents.
    Chackalamannil S
    Curr Top Med Chem; 2003; 3(10):1115-23. PubMed ID: 12769712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.